During the past decade, Hematologische Onkologische Praxis conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hematologische Onkologische Praxis" #1 sponsor was "German CLL Study Group" with 3 trials, followed by "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 3 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored, "Heidelberg University" with 1 trials sponsored and "III. Medizinische Klinik Mannheim" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hematologische Onkologische Praxis" #1 collaborator was "University of Cologne" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Hematologische Onkologische Praxis" are "Chronic Lymphocytic Leukemia" (4 trials), "Lymphoma" (3 trials), "Leukemia" (2 trials), "Anemia" (1 trials) and "Non-Small Cell Lung Cancer (NSCLC)" (1 trials). Many other conditions were trialed in "Hematologische Onkologische Praxis" in a lesser frequency.

Most popular intervention types in "Hematologische Onkologische Praxis" are "Drug" (10 trials), "Biological" (7 trials), "Radiation" (4 trials), "Procedure" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (4 trials), "radiation therapy" (4 trials), "doxorubicin hydrochloride" (3 trials), "filgrastim" (3 trials) and "prednisone" (3 trials). Other intervention names were less common.

The vast majority of trials in "Hematologische Onkologische Praxis" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Hematologische Onkologische Praxis". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Hematologische Onkologische Praxis, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hematologische Onkologische Praxis, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".